About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 230 record(s)
Req # A-2020-001486
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100273-135, 2020 Public Health Agency of Canada Awards Launch.Organization: Health Canada
August 2021
Req # A-2020-001551
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-116013-691, Industry Proposal for Food Advertising Restrictions to Children.Organization: Health Canada
August 2021
Req # A-2021-000040
Adverse Drug Reaction (ADR) for GENVOYA. Report number: E2B_03707140.Organization: Health Canada
August 2021
Req # A-2021-000181
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03757230.Organization: Health Canada
August 2021
Req # A-2021-000182
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03744567.Organization: Health Canada
August 2021
Req # A-2021-000183
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03757246.Organization: Health Canada
August 2021
Req # A-2021-000250
Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report number: E2B_03388071.Organization: Health Canada
August 2021
Req # A-2021-000272
Adverse Drug Reaction (ADR) for Prevegyne. Report number: E2B_03212857.Organization: Health Canada
August 2021
Req # A-2021-000290
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106192-165, ASDM attending the Roadmap for Open Science Steering Committee.Organization: Health Canada
August 2021
Req # A-2021-000294
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105824-424, Ministerial joint meeting with SEUI/CUPE/Unifor.Organization: Health Canada
August 2021